Now accepting Telehealth appointments. Schedule a virtual visit.

The B Vitamin Conversation: What I'm Telling My AMD Patients

By Paddy Kalish, OD

Almost every week, a patient with macular degeneration asks me the same question, usually with a little fear behind it: "Doctor, my mother lost her vision to this. Is there anything I can take so it doesn't happen to me?"

For a long time, my honest answer had a gap in it. We have a proven vitamin formula for intermediate AMD — the AREDS and AREDS2 formulas, which cut the risk of progressing to advanced disease by about 25% in the original AREDS trial. But for early AMD, the stage far more of my patients are actually in, there has been no treatment with real evidence behind it. Nothing. Watch and wait.

That's why a recent conversation caught my attention. On Ready, Set, Retina, Dr. Daniel Epshtein and retina specialist Dr. Priya Vakharia walked through the emerging evidence for something humble: B vitamins. Here's the story as I'd tell it to you in my exam chair.

The heart trial that wasn't supposed to be about eyes

The strongest evidence comes from a study that wasn't even designed for eyes. The Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) randomized 5,442 women with cardiovascular disease or major cardiac risk factors to a daily combination of folic acid, vitamin B6, and vitamin B12 — or to placebo — purely to test heart protection. AMD was tracked almost as an afterthought.

After an average of 7.3 years, the afterthought turned out to be remarkable:

Unlike AREDS, which helps only once drusen have built up to intermediate disease, this is the first randomized evidence that something might lower the risk of AMD developing in the first place. The likely mechanism runs through homocysteine — an amino acid that damages blood vessels when it accumulates, and that B vitamins help clear.

The population data agrees — with an asterisk

The Blue Mountains Eye Study in Australia points the same way. People with vitamin B12 deficiency had 58% higher odds of early AMD and more than double the odds of late AMD, while people who took a B12 supplement had 47% lower odds of any AMD.

Now the asterisk, because you deserve it: Blue Mountains is observational. It shows an association, not proof that the supplement caused the difference. Dr. Vakharia is candid that the whole B-vitamin story is still "hypothesis-generating" — compelling, but not settled science. The B-vitamin evidence comes from cardiovascular and population studies, not from eye-specific trials with retinal imaging as the endpoint.

What about the new AREDS3 on the shelf?

You may already see PreserVision AREDS3 in the pharmacy — a new Bausch + Lomb formula that adds a B-complex blend to the AREDS lineup and lowers the zinc to be gentler on the stomach. It looks sensible. But it has not yet been tested in a dedicated National Eye Institute trial, and I won't pretend otherwise. The established standard today remains AREDS2 for intermediate AMD.

What I actually recommend

Here is my practical take, the same one I give in the office:

And yes, the gummy part is deliberate. I prefer chewables, and my morning supplements are mostly chewables too. My reasons:

The bottom line

B vitamins won't replace your eye exams, your AREDS2, or your sunglasses — and nobody should promise you they prevent AMD outright. But for the early-AMD patient who has had no options, a daily B complex is the first low-risk, evidence-leaning step I've been able to offer with a straight face. If AMD runs in your family, bring it up at your next visit. It's a conversation worth having — and now you know exactly how it goes in my chair.

This article is educational and is not a prescription. Please talk with your own eye doctor before starting or changing any supplement, especially if you already take an AREDS formula or other medications.

You Might Also Enjoy...

Pickleball-Related Eye Injuries

Pickleball-related eye injuries are on the rise due to the sport’s rapid growth in the United States, especially among adults aged 50 and older

Mouth Breathing

Mouth breathing occurs when a person breathes primarily through the mouth rather than the nose, often due to nasal obstruction or other health issues

ALS(Amyotrophic Lateral Sclerosis)

ALS (Amyotrophic Lateral Sclerosis) is a progressive and fatal neurodegenerative disease affecting nerve cells in the brain and spinal cord that control voluntary muscles, leading to muscle weakness, paralysis, and ultimately respiratory failure.

Common Hormones and Their Nicknames

Many hormones also have scientific abbreviations and are grouped by chemical classes (e.g., peptide, steroid, amine). The nicknames often come from their most prominent and publicized effects on health or behavior.

EYES are a WINDOW to the KIDNEYS

"Eyes are a window to the kidneys" is a medically relevant concept, suggesting that eye conditions, particularly those affecting the retina and its microvasculature, can indicate the presence and progression of kidney disease and other systemic conditions

Erysipelas vs. Cellulitis

Erysipelas is a bacterial infection of the skin's upper layers and lymphatic vessels. It is a more superficial infection than cellulitis and is often called "St. Anthony's Fire" due to its fiery, red appearance. Cellulitis involves deeper tissues.